BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 10491363)

  • 1. Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis.
    Witt C; Borges AC; John M; Fietze I; Baumann G; Krause A
    Ann Rheum Dis; 1999 Oct; 58(10):635-40. PubMed ID: 10491363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchoalveolar lavage in systemic sclerosis with lung involvement: role and correlations with functional, radiological and scintigraphic parameters.
    Volpinari S; La Corte R; Bighi S; Ravenna F; Prandini N; Lo Monaco A; Trotta F
    Rheumatol Int; 2011 Sep; 31(9):1183-8. PubMed ID: 20352228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis.
    Wells AU; Hansell DM; Haslam PL; Rubens MB; Cailes J; Black CM; du Bois RM
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1474-82. PubMed ID: 9603126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-8. Differential expression in lone fibrosing alveolitis and systemic sclerosis.
    Southcott AM; Jones KP; Li D; Majumdar S; Cambrey AD; Pantelidis P; Black CM; Laurent GJ; Davies BH; Jeffery PK
    Am J Respir Crit Care Med; 1995 May; 151(5):1604-12. PubMed ID: 7735620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage.
    Silver RM; Miller KS; Kinsella MB; Smith EA; Schabel SI
    Am J Med; 1990 May; 88(5):470-6. PubMed ID: 2337105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung.
    Behr J; Vogelmeier C; Beinert T; Meurer M; Krombach F; König G; Fruhmann G
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):400-6. PubMed ID: 8756813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil activation in fibrosing alveolitis: a comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis.
    Cailes JB; O'Connor C; Pantelidis P; Southcott AM; Fitzgerald MX; Black CM; du Bois RM
    Eur Respir J; 1996 May; 9(5):992-9. PubMed ID: 8793462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis.
    De Santis M; Bosello S; La Torre G; Capuano A; Tolusso B; Pagliari G; Pistelli R; Danza FM; Zoli A; Ferraccioli G
    Respir Res; 2005 Aug; 6(1):96. PubMed ID: 16107215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance.
    Wells AU; Hansell DM; Rubens MB; Cullinan P; Haslam PL; Black CM; Du Bois RM
    Am J Respir Crit Care Med; 1994 Aug; 150(2):462-8. PubMed ID: 8049830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary manifestations of systemic scleroderma: pathophysiologic and clinical significance of the activation of lung fibroblasts].
    Behr J; Adelmann-Grill BC; Hein R; Schwaiblmair M; Degenkolb B; Krombach F; Fruhmann G
    Pneumologie; 1995 Apr; 49(4):266-72. PubMed ID: 7792285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclinical pulmonary involvement assessed by bronchoalveolar lavage in patients with early undifferentiated connective tissue disease.
    Kumánovics G; Zibotics H; Juhász E; Komócsi A; Czirják L
    Clin Exp Rheumatol; 2001; 19(5):551-9. PubMed ID: 11579714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.
    Giacomelli R; Valentini G; Salsano F; Cipriani P; Sambo P; Conforti ML; Fulminis A; De Luca A; Farina G; Candela M; Generini S; De Francisci A; Tirri E; Proietti M; Bombardieri S; Gabrielli A; Tonietti G; Cerinic MM
    J Rheumatol; 2002 Apr; 29(4):731-6. PubMed ID: 11950014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung.
    Chanez P; Lacoste JY; Guillot B; Giron J; Barnéon G; Enander I; Godard P; Michel FB; Bousquet J
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1497-502. PubMed ID: 8503561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast chemotactic response elicited by native bronchoalveolar lavage fluid from patients with fibrosing alveolitis.
    Behr J; Adelmann-Grill BC; Krombach F; Beinert T; Schwaiblmair M; Fruhmann G
    Thorax; 1993 Jul; 48(7):736-42. PubMed ID: 8153923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance.
    Harrison NK; Glanville AR; Strickland B; Haslam PL; Corrin B; Addis BJ; Lawrence R; Millar AB; Black CM; Turner-Warwick M
    Respir Med; 1989 Sep; 83(5):403-14. PubMed ID: 2694236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosing alveolitis in systemic sclerosis: indices of lung function in relation to extent of disease on computed tomography.
    Wells AU; Hansell DM; Rubens MB; King AD; Cramer D; Black CM; du Bois RM
    Arthritis Rheum; 1997 Jul; 40(7):1229-36. PubMed ID: 9214422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL11 in bronchoalveolar lavage fluid and pulmonary function decline in systemic sclerosis.
    Sfriso P; Cozzi F; Oliviero F; Caso F; Cardarelli S; Facco M; Fittà C; Del Rosso A; Matucci-Cerinic M; Punzi L; Agostini C
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S71-5. PubMed ID: 22691213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial lung disease in systemic sclerosis: comparison of BALF lymphocyte phenotype and DLCO impairment.
    Domagała-Kulawik J; Hoser G; Doboszyńska A; Kawiak J; Droszcz W
    Respir Med; 1998 Nov; 92(11):1295-301. PubMed ID: 9926143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression.
    Goh NS; Veeraraghavan S; Desai SR; Cramer D; Hansell DM; Denton CP; Black CM; du Bois RM; Wells AU
    Arthritis Rheum; 2007 Jun; 56(6):2005-12. PubMed ID: 17530640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary involvement in sclerodermia].
    Paone G; Di Michele L; Mattia P; Tonnarini R; Lucifora V; Fiorucci F
    Minerva Med; 1994 Jun; 85(6):293-300. PubMed ID: 8084431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.